Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)

Metastatic germ cell tumor (mGCT) patients receiving chemotherapy have increased risk of life‐threatening venous thromboembolism (VTE). Identifying VTE risk factors may guide thromboprophylaxis in this highly curable population.

[1]  G. Lyman,et al.  Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. , 2018, Thrombosis research.

[2]  Johannes Huber,et al.  Thromboprophylaxis and the route of administration of chemotherapy in testicular cancer patients in German-speaking countries , 2018, World Journal of Urology.

[3]  D. Pfister,et al.  Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer , 2017, Urologia Internationalis.

[4]  T. Hermanns,et al.  Risk stratification for venous thromboembolism in patients with testicular germ cell tumors , 2016, PloS one.

[5]  B. Mellado,et al.  Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients , 2017, Journal of the National Cancer Institute.

[6]  G. Le Teuff,et al.  Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours. , 2016, European journal of cancer.

[7]  C. Jilg,et al.  High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy , 2016, Urologia Internationalis.

[8]  A. Horwich,et al.  Guidelines on Testicular Cancer: 2015 Update. , 2015, European urology.

[9]  Gary H Lyman,et al.  Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Warde,et al.  Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Bokemeyer,et al.  Venous Thromboembolic Events in Germ Cell Cancer Patients Undergoing Platinum-Based Chemotherapy , 2013, Oncology Research and Treatment.

[12]  T. Choueiri,et al.  Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  E. Steyerberg,et al.  [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.

[14]  Gary H Lyman,et al.  Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.

[15]  M. Boccadoro,et al.  Thalidomide for treatment of multiple myeloma: 10 years later. , 2008, Blood.

[16]  A. Folsom,et al.  Chronic kidney disease increases risk for venous thromboembolism. , 2008, Journal of the American Society of Nephrology : JASN.

[17]  C. Théodore,et al.  The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area , 2005, British Journal of Cancer.

[18]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[19]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[20]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[21]  J. Plukker,et al.  Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Roberts,et al.  THROMBOEMBOLIC EVENTS DURING COMBINATION CHEMOTHERAPY FOR GERM CELL MALIGNANCY , 1988, The Lancet.

[23]  W. Whitmore,et al.  Autopsy findings in 154 patients with germ cell tumors of the testis , 1982, Cancer.

[24]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.